LOS ANGELES CAPITAL MANAGEMENT LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$411,136
-67.7%
49,179
-4.0%
0.00%
-60.0%
Q2 2023$1,272,081
+38.1%
51,211
-16.4%
0.01%
+25.0%
Q1 2023$921,305
-51.1%
61,257
-61.5%
0.00%
-55.6%
Q4 2022$1,884,637
+95.1%
159,310
-2.4%
0.01%
+80.0%
Q3 2022$966,000
+79.2%
163,215
+28.8%
0.01%
+66.7%
Q2 2022$539,000
+450.0%
126,706
+1135.0%
0.00%
Q1 2022$98,000
-66.3%
10,260
+36.7%
0.00%
-100.0%
Q2 2021$291,000
-49.9%
7,505
-37.7%
0.00%
-66.7%
Q1 2021$581,000
+157.1%
12,050
+3.9%
0.00%
+200.0%
Q2 2020$226,00011,5980.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders